13F-HR filed by Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-03, with 21 holding rows worth $978,187,000.
- Accession
- 0001567619-21-014327
- Filer
- CIK 924020
- Filed
- 2021-08-03
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 21 entries on the cover page, a total value of $978,187,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $978,187,000 with VALUE read as thousands by filing date, 13F file number 028-20073. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJOHNSON & JOHNSON028-20072
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,379,064 | $293,269,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 3,260,869 | $270,065,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,449,183 | $109,919,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 3,495,575 | $97,876,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,629,173 | $66,878,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 2,898,550 | $44,928,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 3,670,516 | $29,658,000 | thousands by filing date | |
| VOR BIOPHARMA INC | 929033108 | COM | 1,074,658 | $20,042,000 | thousands by filing date | |
| BIOMX INC | 09090D103 | COM | 2,133,402 | $11,648,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 1,000,000 | $10,274,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 728,944 | $7,501,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 1,607,044 | $5,978,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 394,834 | $4,473,000 | thousands by filing date | |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 811,295 | $2,134,000 | thousands by filing date | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 55,435 | $1,319,000 | thousands by filing date | |
| ZYMERGEN INC | 98985X100 | COM | 16,553 | $662,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 84,003 | $545,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 66,951 | $290,000 | thousands by filing date | |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 49,547 | $269,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 5,639 | $249,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 54,621 | $210,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-21-014327 | this filing | 2021-08-03 | acceptance time not in the bulk data set |